PRESS RELEASE published on 09/10/2025 at 05:50, 1 year ago Lobe Sciences Ltd. and Cynaptec Pharmaceuticals, Inc. to Present a New Therapeutic Approach for the Treatment of Chronic Cluster Headaches at Clusterbusters 2025 Lobe Sciences Ltd. to participate in Clusterbusters 20th Annual U.S. Patient Conference to highlight psilocin treatment for cluster headaches and discuss funding success for further research and development Patient Advocacy Conjugated Psilocin Chronic Cluster Headaches Lobe Sciences Ltd. Clusterbusters Conference
BRIEF published on 09/09/2025 at 05:55, 1 year ago Lobe Sciences Appoints Marco Mastrodonato to Board Biopharmaceutical Board Appointment Therapeutic Development Lobe Sciences Marco Mastrodonato
BRIEF published on 09/09/2025 at 05:55, 1 year ago Lobe Sciences nomme Marco Mastrodonato à son conseil d'administration Biopharmaceutique Nomination Au Conseil D'administration Développement Thérapeutique Sciences Du Lobe Marco Mastrodonato
PRESS RELEASE published on 09/09/2025 at 05:50, 1 year ago Lobe Sciences Announces the Appointment of Marco Mastrodonato to its Board of Directors Lobe Sciences Ltd. appoints Marco Mastrodonato to its Board of Directors, bringing extensive experience in pharmaceutical and biotechnology industries, enhancing global business acumen Board Of Directors Pharmaceutical Industry Lobe Sciences Ltd. Marco Mastrodonato Biotechnology Industry
BRIEF published on 08/15/2025 at 05:05, 1 year 1 month ago Lobe Sciences Concludes Private Placement to Raise CAD $341,425 Private Placement Canadian Market Biopharmaceutical Equity Offering Lobe Sciences
BRIEF published on 08/15/2025 at 05:05, 1 year 1 month ago Lobe Sciences conclut un placement privé pour lever 341 425 $ CA Placement Privé Biopharmaceutique Offre D'actions Marché Canadien Sciences Du Lobe
PRESS RELEASE published on 08/15/2025 at 05:00, 1 year 1 month ago Lobe Sciences Announces the Closing of the Previously Announced Private Placement Lobe Sciences completes non-brokered private placement totaling $341,425 CAD. Securities subject to statutory holding period. Developing treatments for rare diseases Private Placement Biopharmaceutical Therapeutics Rare Diseases Lobe Sciences
BRIEF published on 07/29/2025 at 06:15, 1 year 1 month ago Lobe Sciences Announces Private Placement for Corporate Funding Private Placement Biopharmaceutical Investments Corporate Funding Lobe Sciences
BRIEF published on 07/29/2025 at 06:15, 1 year 1 month ago Lobe Sciences annonce un placement privé pour le financement des entreprises Placement Privé Investissements Biopharmaceutique Financement Des Entreprises Sciences Du Lobe
BRIEF published on 07/29/2025 at 06:13, 1 year 1 month ago Lobe Sciences Ltd. Partners with ArcStone for Market Strategy Investor Relations Strategic Partnership Capital Markets Biopharmaceutical Market Positioning
Published on 09/21/2026 at 15:45, 3 hours 7 minutes ago Datavault AI and Cutting-Edge Sports Management Announce Dream Bowl XV at AT&T Stadium and Launch First-of-Its-Kind Bowl Combine
Published on 09/21/2026 at 14:20, 4 hours 32 minutes ago Doctor's Choice(R) Clinically-Proven Scrubs Launching on Amazon Canada
Published on 09/21/2026 at 14:05, 4 hours 47 minutes ago Winners of this Year's Semmelweis-Richter International Journalism Award Announced
Published on 09/21/2026 at 14:00, 4 hours 52 minutes ago Dateline Files Motion to Resume Operations at Colosseum
Published on 09/21/2026 at 13:45, 5 hours 7 minutes ago Nine Mile Metals DDH WD-26-11 Intersects 2 High Grade VMS Zones Over 27.6M Including 3.08% CU-EQ Over 10.70M, 3.27% CU-EQ Over 9.30M and 4.30% CU-EQ Over 5.0M
Published on 09/21/2026 at 18:00, 52 minutes ago Cham Swiss Properties places bond of CHF 100 million
Published on 09/21/2026 at 17:45, 1 hour 7 minutes ago EQS-Adhoc: Airbus reports share buyback transactions 11-18 September 2026
Published on 09/21/2026 at 17:45, 1 hour 7 minutes ago Charwood Energy poursuit sur un rythme de croissance élevé. Chiffre d’affaires semestriel en hausse de +43 % à 5,6 M€.
Published on 09/21/2026 at 17:45, 1 hour 7 minutes ago Charwood Energy continues to grow at a strong pace. H1 revenue up +43% to €5.6m.
Published on 09/21/2026 at 17:00, 1 hour 52 minutes ago Menarini Group and NewAmsterdam Pharma Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
Published on 09/21/2026 at 18:19, 33 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain du 14 au 18 septembre 2026
Published on 09/21/2026 at 18:19, 33 minutes ago Reporting on share buyback transactions carried out between September 14 and September 18, 2026
Published on 09/21/2026 at 18:01, 51 minutes ago Partnership agreement signed between Manitou Group and HD Construction Equipment
Published on 09/21/2026 at 17:46, 1 hour 6 minutes ago WEB SA - STATUTORY HALF-YEAR RESULTS AS OF 30/06/2026
Published on 09/21/2026 at 17:46, 1 hour 6 minutes ago WEB SA - RESULTATS SEMESTRIELS STATUTAIRES AU 30/06/2026
